“The Diagnostic Value of Anti-Mullerian Hormone and Follicular Stimulating Hormone in Polycystic Ovary Syndrome Patients”, jchm, vol. 1, no. 1, Dec. 2022, doi: 10.59628/jchm.v1i1.85.